Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis

Zhi Li, Sanjeewa G. Rupasinghe, Mary A Schuler, Satish K Nair

Research output: Contribution to journalArticle

Abstract

The lipoglycopeptide antibiotic teicoplanin has proven efficacy against gram-positive pathogens. Teicoplanin is distinguished from the vancomycin-type glycopeptide antibiotics, by the presence of an additional cross-link between the aromatic amino acids 1 and 3 that is catalyzed by the cytochrome P450 monooxygenase Orf6* (CYP165D3). As a goal towards understanding the mechanism of this phenol-coupling reaction, we have characterized recombinant Orf6* and determined its crystal structure to 2.2-Å resolution. Although the structure of Orf6* reveals the core fold common to other P450 monooxygenases, there are subtle differences in the disposition of secondary structure elements near the active site cavity necessary to accommodate its complex heptapeptide substrate. Specifically, the orientation of the F and G helices in Orf6* results in a more closed active site than found in the vancomycin oxidative enzymes OxyB and OxyC. In addition, Met226 in the I helix replaces the more typical Gly/Ala residue that is positioned above the heme porphyrin ring, where it forms a hydrogen bond with a heme iron-bound water molecule. Sequence comparisons with other phenol-coupling P450 monooxygenases suggest that Met226 plays a role in determining the substrate regiospecificity of Orf6*. These features provide further insights into the mechanism of the cross-linking mechanisms that occur during glycopeptide antibiotics biosynthesis.

Original languageEnglish (US)
Pages (from-to)1728-1738
Number of pages11
JournalProteins: Structure, Function and Bioinformatics
Volume79
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Teicoplanin
Biosynthesis
Mixed Function Oxygenases
Phenol
Glycopeptides
Crystal structure
Vancomycin
Anti-Bacterial Agents
Heme
Catalytic Domain
Aromatic Amino Acids
Porphyrins
Pathogens
Substrates
Cytochrome P-450 Enzyme System
Hydrogen
Hydrogen bonds
Iron
Molecules
Water

Keywords

  • Cytochrome P450 monooxygenase
  • Glycopeptide antibiotic
  • Teicoplanin
  • Vancomycin

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry
  • Molecular Biology

Cite this

Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis. / Li, Zhi; Rupasinghe, Sanjeewa G.; Schuler, Mary A; Nair, Satish K.

In: Proteins: Structure, Function and Bioinformatics, Vol. 79, No. 6, 01.06.2011, p. 1728-1738.

Research output: Contribution to journalArticle

@article{0f9914a3303e42dabce0db31f41e8e8d,
title = "Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis",
abstract = "The lipoglycopeptide antibiotic teicoplanin has proven efficacy against gram-positive pathogens. Teicoplanin is distinguished from the vancomycin-type glycopeptide antibiotics, by the presence of an additional cross-link between the aromatic amino acids 1 and 3 that is catalyzed by the cytochrome P450 monooxygenase Orf6* (CYP165D3). As a goal towards understanding the mechanism of this phenol-coupling reaction, we have characterized recombinant Orf6* and determined its crystal structure to 2.2-{\AA} resolution. Although the structure of Orf6* reveals the core fold common to other P450 monooxygenases, there are subtle differences in the disposition of secondary structure elements near the active site cavity necessary to accommodate its complex heptapeptide substrate. Specifically, the orientation of the F and G helices in Orf6* results in a more closed active site than found in the vancomycin oxidative enzymes OxyB and OxyC. In addition, Met226 in the I helix replaces the more typical Gly/Ala residue that is positioned above the heme porphyrin ring, where it forms a hydrogen bond with a heme iron-bound water molecule. Sequence comparisons with other phenol-coupling P450 monooxygenases suggest that Met226 plays a role in determining the substrate regiospecificity of Orf6*. These features provide further insights into the mechanism of the cross-linking mechanisms that occur during glycopeptide antibiotics biosynthesis.",
keywords = "Cytochrome P450 monooxygenase, Glycopeptide antibiotic, Teicoplanin, Vancomycin",
author = "Zhi Li and Rupasinghe, {Sanjeewa G.} and Schuler, {Mary A} and Nair, {Satish K}",
year = "2011",
month = "6",
day = "1",
doi = "10.1002/prot.22996",
language = "English (US)",
volume = "79",
pages = "1728--1738",
journal = "Proteins: Structure, Function and Bioinformatics",
issn = "0887-3585",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis

AU - Li, Zhi

AU - Rupasinghe, Sanjeewa G.

AU - Schuler, Mary A

AU - Nair, Satish K

PY - 2011/6/1

Y1 - 2011/6/1

N2 - The lipoglycopeptide antibiotic teicoplanin has proven efficacy against gram-positive pathogens. Teicoplanin is distinguished from the vancomycin-type glycopeptide antibiotics, by the presence of an additional cross-link between the aromatic amino acids 1 and 3 that is catalyzed by the cytochrome P450 monooxygenase Orf6* (CYP165D3). As a goal towards understanding the mechanism of this phenol-coupling reaction, we have characterized recombinant Orf6* and determined its crystal structure to 2.2-Å resolution. Although the structure of Orf6* reveals the core fold common to other P450 monooxygenases, there are subtle differences in the disposition of secondary structure elements near the active site cavity necessary to accommodate its complex heptapeptide substrate. Specifically, the orientation of the F and G helices in Orf6* results in a more closed active site than found in the vancomycin oxidative enzymes OxyB and OxyC. In addition, Met226 in the I helix replaces the more typical Gly/Ala residue that is positioned above the heme porphyrin ring, where it forms a hydrogen bond with a heme iron-bound water molecule. Sequence comparisons with other phenol-coupling P450 monooxygenases suggest that Met226 plays a role in determining the substrate regiospecificity of Orf6*. These features provide further insights into the mechanism of the cross-linking mechanisms that occur during glycopeptide antibiotics biosynthesis.

AB - The lipoglycopeptide antibiotic teicoplanin has proven efficacy against gram-positive pathogens. Teicoplanin is distinguished from the vancomycin-type glycopeptide antibiotics, by the presence of an additional cross-link between the aromatic amino acids 1 and 3 that is catalyzed by the cytochrome P450 monooxygenase Orf6* (CYP165D3). As a goal towards understanding the mechanism of this phenol-coupling reaction, we have characterized recombinant Orf6* and determined its crystal structure to 2.2-Å resolution. Although the structure of Orf6* reveals the core fold common to other P450 monooxygenases, there are subtle differences in the disposition of secondary structure elements near the active site cavity necessary to accommodate its complex heptapeptide substrate. Specifically, the orientation of the F and G helices in Orf6* results in a more closed active site than found in the vancomycin oxidative enzymes OxyB and OxyC. In addition, Met226 in the I helix replaces the more typical Gly/Ala residue that is positioned above the heme porphyrin ring, where it forms a hydrogen bond with a heme iron-bound water molecule. Sequence comparisons with other phenol-coupling P450 monooxygenases suggest that Met226 plays a role in determining the substrate regiospecificity of Orf6*. These features provide further insights into the mechanism of the cross-linking mechanisms that occur during glycopeptide antibiotics biosynthesis.

KW - Cytochrome P450 monooxygenase

KW - Glycopeptide antibiotic

KW - Teicoplanin

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=79955706018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955706018&partnerID=8YFLogxK

U2 - 10.1002/prot.22996

DO - 10.1002/prot.22996

M3 - Article

C2 - 21445994

AN - SCOPUS:79955706018

VL - 79

SP - 1728

EP - 1738

JO - Proteins: Structure, Function and Bioinformatics

JF - Proteins: Structure, Function and Bioinformatics

SN - 0887-3585

IS - 6

ER -